Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

CVS Health Corporation : Expectation of a turn-around

08/20/2020 | 08:06am EST
long trade under condition
Stop-loss triggered
Entry price : 66$ | Target : 70.62$ | Stop-loss : 63.3$ | Cancellation Level : 61.15$ | Potential : 7%
CVS Health Corporation reflects attractive technical aspects that could allow investors to expect a trend reversal over the medium term.
Investors should benefit from the breakout of the $ 66 level to target the $ 70.62.
CVS Health Corporation : CVS Health Corporation : Expectation of a turn-around
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • Historically, the company has been releasing figures that are above expectations.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.53 for the 2020 fiscal year.
  • With a P/E ratio at 11.45 for the current year and 10.73 for next year, earnings multiples are highly attractive compared with competitors.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses
  • The company sustains low margins.

© MarketScreener.com 2020

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2020 268 B - -
Net income 2020 7 522 M - -
Net Debt 2020 55 969 M - -
P/E ratio 2020 13,4x
Yield 2020 2,63%
Capitalization 99 818 M 99 818 M -
EV / Sales 2020 0,58x
EV / Sales 2021 0,52x
Nbr of Employees 290 000
Free-Float 75,4%
Upcoming event on CVS HEALTH CORPORATION
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 85,68 $
Last Close Price 76,26 $
Spread / Highest target 33,8%
Spread / Average Target 12,4%
Spread / Lowest Target -9,52%
EPS Revisions
Managers and Directors
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORPORATION11.65%99 818
HCA HEALTHCARE, INC.2.62%57 107
FRESENIUS MEDICAL CARE AG & CO. KGAA-0.97%23 889
LABORATORY CORPORATION OF AMERICA HOLDINGS9.90%21 789
QUEST DIAGNOSTICS4.38%16 764
DAVITA INC.1.15%13 300